|
ZNF200 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.004730E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.735900E-02 |
| Normal-vs-Stage2 |
7.000000E-02 |
| Normal-vs-Stage3 |
1.143550E-02 |
| Normal-vs-Stage4 |
3.739200E-01 |
| Stage1-vs-Stage2 |
3.731200E-01 |
| Stage1-vs-Stage3 |
5.902300E-02 |
| Stage1-vs-Stage4 |
9.832600E-01 |
| Stage2-vs-Stage3 |
5.605200E-01 |
| Stage2-vs-Stage4 |
5.852800E-01 |
| Stage3-vs-Stage4 |
3.353600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.295130E-03 |
| Normal-vs-AfricanAmerican |
5.139500E-02 |
| Normal-vs-Asian |
9.485800E-02 |
| Caucasian-vs-AfricanAmerican |
5.476600E-01 |
| Caucasian-vs-Asian |
9.169200E-01 |
| AfricanAmerican-vs-Asian |
7.406400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.797500E-03 |
| Normal-vs-Female |
3.923800E-03 |
| Male-vs-Female |
4.947800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.966040E-01 |
| Normal-vs-Extreme_Weight |
1.338430E-01 |
| Normal-vs-Obese |
2.718600E-03 |
| Normal-vs-Extreme_Obese |
8.045400E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.447600E-01 |
| Normal_Weight-vs-Obese |
9.284300E-02 |
| Normal_Weight-vs-Extreme_Obese |
6.455400E-01 |
| Extreme_Weight-vs-Obese |
5.034200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.438600E-01 |
| Obese-vs-Extreme_Obese |
2.190400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.882200E-03 |
| Normal-vs-Age(41-60Yrs) |
4.036200E-04 |
| Normal-vs-Age(61-80Yrs) |
2.442100E-02 |
| Normal-vs-Age(81-100Yrs) |
6.194800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.346400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.935800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.164820E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.636840E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.823020E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.079200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.169000E-04 |
| Normal-VS-Type2 PRCC |
4.967000E-01 |
| Normal-VS-KIRP CIMP |
3.119700E-02 |
| Normal-VS-Unclassified PRCC |
5.395600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.312000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.879200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.165400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.728300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.536330E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.144400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.643400E-01 |
| Normal-vs-N1 |
9.634500E-04 |
| Normal-vs-N2 |
1.461170E-01 |
| N0-vs-N1 |
3.697800E-03 |
| N0-vs-N2 |
2.042200E-01 |
| N1-vs-N2 |
3.239800E-02 |
|
|
